Package 43063-778-90

{"route": ["ORAL"], "spl_id": "47a74d7e-7032-ca99-e063-6294a90ab0e2", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313565"], "spl_set_id": ["91a738da-96c7-44f2-8878-df6a75abdf08"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "10 TABLET in 1 BOTTLE, PLASTIC (43063-778-10)", "package_ndc": "43063-778-10", "marketing_start_date": "20170801"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE, PLASTIC (43063-778-14)", "package_ndc": "43063-778-14", "marketing_start_date": "20170811"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (43063-778-90)", "package_ndc": "43063-778-90", "marketing_start_date": "20180806"}], "brand_name": "Valacyclovir Hydrochloride", "product_id": "43063-778_47a74d7e-7032-ca99-e063-6294a90ab0e2", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "43063-778", "generic_name": "Valacyclovir hydrochloride", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir Hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA077135", "marketing_category": "ANDA", "marketing_start_date": "20100524", "listing_expiration_date": "20271231"}